Cell preservation prosperity: BioLife and Cryoport up on personalised meds – BioPharma-Reporter.com
BioPharma-Reporter.com |
Cell preservation prosperity: BioLife and Cryoport up on personalised meds
BioPharma-Reporter.com … which offers media and logistics services for cell-based therapy developers, boasted preliminary 2016 media sales of $8.2m, up 28% on the previous year. “BioLife's proprietary, clinical grade biopreservation media products, CryoStor and … |
